Sulfadiazine Silver/Sulfadiazine Zinc

磺胺嘧啶银/磺胺嘧啶锌

Report date: 2023/02/17 20:00:35

Base Information

Drug NameSulfadiazine Silver/Sulfadiazine Zinc
Drug Alias Name复方磺胺嘧啶锌乳膏
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA bindersDihydropteroate synthase inhibitors
TargetsDNADihydropteroate synthase
Therapy Area/IndicationsBacterial Infections and Mycoses
Global Approved IndicationsBacterial Infections and Mycoses
Approved Indications in ChinaBacterial Infections and Mycoses
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Sulfadiazine SilverSulfadiazine Zinc
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesChengdu First Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBacterial Infections and Mycoses
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A